<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/225847F1-D0D1-4003-BE43-679724C0EAB8"><gtr:id>225847F1-D0D1-4003-BE43-679724C0EAB8</gtr:id><gtr:name>Biopharma Technology Limited</gtr:name><gtr:address><gtr:line1>BIOPHARMA HOUSE , 9 WINNALL VALLEY ROAD</gtr:line1><gtr:city>WINCHESTER</gtr:city><gtr:postCode>SO23 0LD</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/225847F1-D0D1-4003-BE43-679724C0EAB8" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>225847F1-D0D1-4003-BE43-679724C0EAB8</gtr:id><gtr:name>Biopharma Technology Limited</gtr:name><gtr:address><gtr:line1>BIOPHARMA HOUSE , 9 WINNALL VALLEY ROAD</gtr:line1><gtr:city>WINCHESTER</gtr:city><gtr:postCode>SO23 0LD</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>161000.0</gtr:offerGrant><gtr:projectCost>269636.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/861F8065-9BC3-4A6F-8701-22BD2B010084" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>861F8065-9BC3-4A6F-8701-22BD2B010084</gtr:id><gtr:name>Agform Limited</gtr:name><gtr:address><gtr:line1>MAIDENSTONE HEATH , BLUNDELL LANE</gtr:line1><gtr:city>SOUTHAMPTON</gtr:city><gtr:postCode>SO31 1AA</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>189000.0</gtr:offerGrant><gtr:projectCost>449536.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/8C31C3F2-150C-4EFC-A633-4ACA384C6C4C"><gtr:id>8C31C3F2-150C-4EFC-A633-4ACA384C6C4C</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:surname>Cowen</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=100881"><gtr:id>622A2F82-6C48-4C8E-A68E-2167146C31DA</gtr:id><gtr:title>Novel formulations to reduce environmental exposure of approved herbicide compounds</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Collaborative R&amp;D</gtr:grantCategory><gtr:grantReference>100881</gtr:grantReference><gtr:abstractText>The project aims to identify novel approaches to the processing and formulation of herbicides; that will enable enhanced bio-availability; this will allow lower application rates to be used without loss of efficacy. This will allow the same weed control action to be achieved with a lower rate of application, thus reducing overall environmental exposure. The project will focus on a small number of widely used herbicides to maximise the commercial and environmental gain. This project will have substantial spill-over benefits throughout the supply chain, with lower manufacturing and transportation costs, safer handling and reduced environmental impact. The project involves investigating new and current technology, studying processes used in other industries and bringing these skills to the agricultural industry. The project partners expect that the processes and principles identified in this project will be applicable to a number of other compounds.</gtr:abstractText><gtr:fund><gtr:end>2012-10-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2010-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>350000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">100881</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>